Pfizer's Veteran Science Chief Mikael Dolsten Announces Departure
Search our blog for articles and insights right here, just type your interest and dive into a world of knowledge.
Popular articles
Pfizer Chief Scientific Officer Mikael Dolsten to Step Down After 15 Years
Pfizer has announced that Mikael Dolsten, the company's chief scientific officer and a pivotal figure in the development of its COVID-19 vaccine, will be stepping down. Dolsten has had a notable career spanning over 15 years with the pharmaceutical giant.
The company revealed that the process to identify Dolsten's successor is set to commence, which is anticipated to take several months. Dolsten's journey with Pfizer began following the Wyeth acquisition in 2009, when he was appointed president of Worldwide Research and Development. Since then, he has been instrumental in leading Pfizer's research and overseeing the development of treatments through mid-stage studies.
